PRESS RELEASE 2017

New Ready-to-Drink Low-Volume Colonoscopy Prep in a Premixed Liquid Solution Parsippany, NJ – November 29, 2017 – The U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral ...

PARSIPPANY, NJ (October 30, 2017) – Today Ferring Pharmaceuticals announced results from MEGASET HR, a 620 patient, prospective study comparing MENOPUR (highly purified menotropin, or HP-hMG) to recombinant follicle stimulating hormone (rFSH) in patients predicted to be high-responders to ovarian...

Ferring Pharmaceuticals announced today that it will donate $25,000 to help the people and communities impacted by Hurricane Harvey. Ferring will make its donation to the American Red Cross, which has mobilized its resources to respond to the devastation in Texas and across the Gulf Coast region.

Ferring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of Ferring Holding Inc. In this role Mr. Navarre assumes direct responsibility for all Ferring US activities including commercial operations, clinical development and manufacturing. He succeeds Aa...

Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer and made a member of the Ferring Group Executive Board, effective immediately.

PARSIPPANY, NJ (April 24, 2017) – Infertility is no longer something that people feel they must discuss behind closed doors. Gone are the days of hushed voices and cover stories; now, hardly a day goes by without another celebrity couple sharing that they have frozen their eggs, are undergoing fe...